Compare MXC & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MXC | PMI |
|---|---|---|
| Founded | 1972 | 1981 |
| Country | United States | United States |
| Employees | N/A | 75 |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 14.1M |
| IPO Year | 1995 | N/A |
| Metric | MXC | PMI |
|---|---|---|
| Price | $7.51 | $0.16 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.5K | ★ 8.8M |
| Earning Date | 02-10-2026 | 06-18-2026 |
| Dividend Yield | ★ 1.02% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.63 | N/A |
| Revenue | ★ $2,705,235.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.92 | ★ N/A |
| Revenue Growth | ★ 7.12 | N/A |
| 52 Week Low | $7.16 | $0.11 |
| 52 Week High | $16.48 | $13.68 |
| Indicator | MXC | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 39.48 |
| Support Level | N/A | $0.15 |
| Resistance Level | $9.56 | $0.27 |
| Average True Range (ATR) | 0.46 | 0.02 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 46.41 | 38.15 |
Mexco Energy Corporation is an independent oil and gas company. It is engaged in the acquisition, exploration, development, and production of natural gas and crude oil properties located in the United States. The company carried out its operation in the Permian Basin of West Texas. It is focusing on two primary areas, the Delaware Basin located in the Western portion of the Permian Basin including Lea and Eddy Counties, New Mexico and Loving County, Texas, and the Midland Basin located in the Eastern portion of the Permian Basin including Reagan, Upton, Midland, Martin, Howard, and Glasscock Counties, Texas. The company generates revenue from Oil sales, Natural gas sales, oil and gas royalty interests.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.